AnaptysBio, Inc.ANABNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+183.6%
5Y CAGR+25.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+183.6%/yr
vs +19.8%/yr prior
5Y CAGR
+25.6%/yr
Recent acceleration
Acceleration
+163.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$234.60M+157.0%
2024$91.28M+432.0%
2023$17.16M+66.8%
2022$10.29M-83.7%
2021$63.17M-15.8%
2020$75.00M+837.5%
2019$8.00M+60.0%
2018$5.00M-50.0%
2017$10.00M-40.1%
2016$16.68M-